Owji, Nazanin;
(2020)
Development of 3D Printable Composites for Cranio-Maxillofacial Applications.
Doctoral thesis (Ph.D), UCL (University College London).
Preview |
Text
Owji_10106537_thesis.pdf Download (142MB) | Preview |
Abstract
The worldwide incidence of bone disorders has increased steeply in the past decade; in the craniofacial region specifically, congenital disorders, traumatic incidents and tumour removals are the major causes of bone loss. This has encouraged the emergence of bone tissue engineering substitutes as an alternative method to conventional bone grafts. However, the current approaches in the field face several limitations that has prevented the ultimate translation into clinical settings. In this project, a light curable methacrylate-based polymer, polypropylene glycol dimethacrylate (PPGDMA), was initially investigated for the purpose of reconstructing cranial defects. A mixture of monocalcium phosphate monohydrate and beta tri-calcium phosphate was incorporated in the polymer as the powder phase of choice. The experimental work involved optimisation of flowability of the polymer for 3D printing. Subsequently, the composite discs were fabricated by exposing 11 mm diameter discs to blue light; the rate of the monomer conversion was also determined upon photo-polymerisation with minimum of 62% conversion rate. Finally, the cytocompatibility of the composite discs was verified by seeding MC3T3 osteoprogenitor cells. The second part of this project involved the synthesis of a novel degradable polymer which was aimed at resorting maxillofacial deficiencies: ((((((((((((3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diyl)bis(oxy))bis(ethane- 2,1 diyl))bis(oxy))bis(carbonyl))bis(azanediyl))bis(methylene))bis(3,3,5- trimethylcyclohexane-5,1-diyl))bis(azanediyl))bis(carbonyl))bis(oxy))bis(ethane- 2,1-diyl) bis(2-methylacrylate was referred to as CSMA-2. Nuclear Magnetic Resonance (NMR) analysis initially confirmed formation of this monomer. Stiffness was tested using a biaxial flexural test and the values were found to be 1.8-2.7 x 103 N.mm -2 in CSMA-2 and the composites. In vitro cell culture, using human bone marrow derived mesenchymal stem cells (BMSCs), confirmed non-toxicity of the samples. This was followed by in vivo assessment of CSMA-2 in a rat model; sign of neo-bone formation 8 weeks post implantation of CSMA-2 further verified noncytotoxicity of the polymer. Finally, Digital Light Processing (DLP) 3D printing allowed direct photo-polymerisation and setting of the bio ink into a mesh-like construct.
| Type: | Thesis (Doctoral) |
|---|---|
| Qualification: | Ph.D |
| Title: | Development of 3D Printable Composites for Cranio-Maxillofacial Applications |
| Event: | UCL (University College London) |
| Open access status: | An open access version is available from UCL Discovery |
| Language: | English |
| Additional information: | Copyright © The Author 2020. Original content in this thesis is licensed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) Licence (https://creativecommons.org/licenses/by/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10106537 |
Archive Staff Only
 |
View Item |
